sympathetic nerve impulses endogenous catecholamines beta adrenergic drugs

Size: px
Start display at page:

Download "sympathetic nerve impulses endogenous catecholamines beta adrenergic drugs"

Transcription

1 Beta adrenergic blockers } These drugs will bind and prevent beta-receptors from responding to: sympathetic nerve impulses endogenous catecholamines beta adrenergic drugs the use of beta antagonists is generally preferred over the use of alpha antagonists because alpha antagonists are associated with more adverse reactions. Beta receptors blockers are divided into primary subgroups depending on their receptor selectivity into: 1-non selectice beta blockers (block both Beta1 and Beta 2) 2- Beta 1 selective 3- Beta 2 selective the primary groups are beta 1 selective and non beta selective. beta blockers usually end with the suffix ( lol). Beta-1,2-Non-Selective Propranolol [INDERAL] Nadolol [CORGARD] Carteolol [CARTROL] * Timolol [BLOCADREN] Pindolol [VISKEN] * Sotalol [BETAPACE] Penbutool [LEVATOL] Beta-1-Selective

2 Acebutolol [SECTRAL] * Atenolol [TENORMIN] Betaxolol [KERIONE] Bisoprolol [ZEBETA] Esmolol [BREVIBLOC] Metoprolol [LOPRESSOR ] Nebivolol? Now in addition to these two primary subgroups ( beta nonselective and beta 1 selective ) we have another class that is Non-selective beta blocker and selective alpha 1 blocker meaning that they antagonize both beta 1 and beta 2 receptors as well as alpha 1 receptors : -Labetalol [TRANDATE, NORMODYNE] -Carvedilol [COREG] -the beta 1 selective drugs are superior to the non-selective drugs in their indications. (better than nonselective due to lesser side effects ). notes of some of the aforementioned drugs : ** propranolol is the prototype. (it is non-selective ) and is a highly lipid soluble drug thus capable of penetrating the BBB into the brain. ** long acting drugs : -Nadolol is the longest acting(-longest duration of action-) among all of beta blockers. (last for 24 hours). -Nebivolol has also long duration of action (lasts for 30 hours) ( the doctor said it this way for nadolol and nebivolol so just consider them both to have a long duration of action!).

3 **short acting drugs : -Esmolol is the shortest acting and thus usually given by infusion. it is used for supraventricular tachycardia to reduce Heart Rate in those patients. **-Nebivolol is not only a selective beta 1 blocker but has also shown to release Nitric Oxide, and this release of nitric oxide will cause further dilatation of blood vessels. so it is a very good drug for lowering hypertension due to both effects : on heart (by its beta 1 selective blocking) and on peripheral resistance (due to release of nitric oxide) (remember BP=CO *PVR). **-Acebutalol(beta 1 selective) and pindalol(non-selective) they have in addition to their beta blocking effect an ability called intrinsic sympathomymetic ability, meaning although they are blocking agents they can stimulate the same receptors they are blocking. we will see how this could be a very good feature for some conditions. THE NON-SELECTIVE AGENTS -Propranolol, sotalol, nadolol, pindolol and timolol. -These agents will block both beta 1 and beta 2 receptors so they will produce decreasing in HR and contractility of heart muscle( because of beta 1 blocking ) and bronchoconstriction (due to beta 2 blocking ) and that s why its a major disadvantage for patients who have ASTHMA and are in need of beta blockers to use the non selective ones. -The non-selective beta blockers will cause an increase in peripheral vasoconstriction due to two reasons : 1-because of it s effect on beta 1 receptors, it will lead to decrease in Heart rate and Cardiac output, so as a compensation the Peripheral vascular resistance will increase by constricting peripheral vessels ( as we said the formula is like this BP=CO*PVR,, so the body will try to change one if the other changed to keep BP) 2- because of it s effect on beta 2 receptors it will lead to vasoconstriction of the vessels in the skeletal muscles(beta 2 receptors activation leads to dilatation of the vessels in the skeletal muscles so blocking it will lead to vasoconstriction) Now because of those two reasons the non-selective beta blockers will lead to increase in peripheral vasoconstriction so these drugs are NOT used in peripheral vascular disease patients. *(note that the same thing is applied for selective beta 1 blockers but only due to the first reason ( the compensatory one to decreasing the CO ) and not due to the second reason (because of having no activity on the beta 2 receptors.

4 3- these drugs will also inhibit glycogenolysis through antagonizing the beta 2 receptors which will disrupt the metabolic balance causing hypoglycemia (as a result of decreased glycogenolysis) and that s especially dangerous for diabetic patients who are already hypo glycemic because o their insulin treatment. } Bronchoconstriction, } Peripheral vasoconstriction } Interference with glycogenolysis - propranolol is indicated in treatment of : 1-hypertension, dysrhythmia (also Esmolol is used in arrhythmia supraventricular tachycardia-, but Esmolol is selective ), angina pectoris, MI. 2- in pheocromcytoma (in conjunction with alpha blockers,,, remember pheocromcytoma is a tumor of the adrenal medulla characterized by increase in epinephrine secretion,, the pheocromcytoma treatment is by surgery, but during surgery we might cause release of epinephrine so our initial management will be using alpha blockers FIRST so that the released epinephrine wont work on peripheral vessels (alpha 1 blocking) and then continuing with beta blockers ) 3- migraine (the propranolol is lipid soluble, crosses CNS so causes effects there to treat migraine) Now in the next page we have a table the doctor showed in the lec,, but the only thing the doctor focused on is that : most of the beta blockers have low lipid solubility except for propranolol which has high lipid solubility making it able to enter CNS,hence its use in migraines.

5

6 Moving on to the EFFECTS OF BETA BLOCKERS : - Decrease Heart rate. - Decrease force of contraction. - Decrease cardiac output. - Slow cardiac conduction. - Decrease automacity of ectopic pacemakers. **Decrease renin secretion from kidney..and as a result a drop in the blood pressure. **they may increase VLDL and decrease HDL. **they decrease portal pressure of patients with cirrhosis (in slides) clinical note about these drugs(masking effect ) : the use of these drugs must be extremely restricted to diabetic patients because these patients are on insulin treatment which may induce hypoglycemia this hypoglycemia normally presents with clinical symptoms (convulsions, tremor, anxiety,sweating..)mediated by an intrinsic compensatory sympathetic outflow to the hypoglycemic state. now giving beta blockers (sympatholytic agents )to these patients will negate the compensatory sympathetic effect and mask it s symptoms on the patient while hypoglycemia worsens in the background with no indication. note the only clinical effect of hypoglycemia that persists when giving beta blockers is sweating because sweat glands has sympathetic muscarinic acetylcholine receptors. so from the previous paragraph the two important notes are : 1- Non-selective beta blockers should not be used in diabetic patients on insulin. 2- All sympathetic symptoms of hypoglycemia are masked by nonselective beta blockers except sweating (uses ACH on muscarinic, an exception)

7

8 BETA 1 SELECTIVE drugs } (Acebutolol, atenolol, metoprolol and esmolol ) are relatively cardioselective -we said relatively because this cardioselectivity might be lost in high doses of the drug,, so their not 100% selective -beta 1 selective drugs at normal doses >> affects only beta 1 receptors (cardioselective) -beta 1 selective drugs at high doses >> affects both beta 1 and beta 2 receptors ( lost their selectivity) -generally these drugs are superior to non-selective beta blockers ( better ), because of their selectivity, so we can use them in patients with hypertension who also have other medical conditions as : (ASTHMA, PERIPHRAL VASCULAR DISEASE and DIABETES mellitus ). The doctor read the following table :

9 Some notes about the table : -Labetolol and carvedolol are non selective beta and alpha 1 antagonists. -labetolol is : safe during pregnancy and used in hypertensive crisis and malignant hypertension. -labetalol and carvedolol have postural hypotension as a side effect due to alpha 1 antagonizing.** Advantages of drugs that are rendered as beta blockers while at the same time having intrinsic sympathomimetic effects : ( Acebutolol, Pindolol): As a result of having this activity.( bradycardia that is produced by other drugs of the beta blocker family can be counter acted by acebutolol i.e. their intrinsic sympathomimetic activity improves bradycardia ) Thus these drugs can be given in hypertensive cases where the heart is suffering from bradycardia). See the following figure and illustration for better understanding : Propranolol and atenolol have no partial sympathetic activity And as noted you can observe the decrease in the cardiac output and the heart rate after the use of such drugs(because they re beta blockers dauh?)

10 Compared to acebutolol ( which has an intrinsic sympathomimetic activity)which causes lesser reduction in the cardiac output and heart rate And finally you can see the pattern of behavior of pindolol which shows no to little reduction in the heart rate and the cardiac output, again because of it s intrinsic sympathomimetic activity. And that s why patients who are hypertensive while at the same time suffering from a decreased heart rate, are best treated with (pindolol and acebutolol) when beta antagonists are required. Uses of beta blockers : I. used in treatment of coronary artery disease (i.e. ischemic heart disease) and as a preventive measure for this condition as well. According to this graph the number of total deaths as well as the number of sudden deaths following an ischemic heart disease is significantly lower in patients who are on beta blockers(hence them being used as a treatment). The number of patients who survived an ischemic attack and then suffered from re-infarction is less in those who are on beta blockers ( thus the preventive use of the drugs ).

11 I. beta blockers can be used for treatment of hypertension through acting on the following mechanisms : a)decreasing the heart rate and the force of contraction thus having a total reduction effect on the cardiac output and subsequently lowering blood pressure. b) we learned previously that beta agonists can increase the secretion of renin, thus their antagonist will decrease it leading to a decrease in the concentration of its products such as angiotensin 2, now a reduced level of angiotensin 2 will lead to the loss of its direct constrictive effect on the blood vessels ( thus we have a net result of vasodilation and a decrease in the peripheral resistance) and also a decrease of angiotensin s own subsequent products as aldosterone. which results in less Na and water reuptake by the kidneys and a drop in the blood pressure. c)decreased central sympathetic outflow through working on the beta 2 presynaptic receptors in the central nervous system. as illustrated in the figure below : beta presynaptic receptors whose upon binding with a ligand, increases the rate of release of nor-epinephrine and other catecholamines will be blocked and a total decrease in the central sympathetic outflow will yield. (-mainly propranolol because as we said its lipid soluble and has access to the central nervous system-).

12 d) through working on other pre-junctional receptors(reduced catecholamine release) II. used as anti arrhythmic agents ( specifically : esmolol,oxprenolol,propanolol ) as you can see in the following graphs fluctuations in the heart rate and contractility (i.e. arrhythmic effects ) are evident after a stressful exciting stimuli (a football game as mentioned by the dr ). whereas after the administration of beta blockers these fluctuations were abolished as a result of the antiarrhythmic heart stabilizing properties of beta blockers. III. congestive heart failure : now you may find it a bit odd that in a case where the primary concern is a reduction in the contractility and the cardiac output of the heart

13 agents that antagonize beta receptors are implemented in the treatment. and that s totally fine because it doesn t make any sense. its just that studies found that in some patients with specific cases of congestive heart failure have improved following the use of some beta blockers as part of their treatment regimen. But the use must be tightly regulated,taken into consideration that only specific beta blockers (example :metoprolol)are used in some patients in specific cases where they are considered hemodynamiclly stable and only by experienced doctors. Illustrated by the figure: the cumulative mortality rate of congestive heart failure has dropped after the use of beta blockers.

14 IV. hypertrophic obstructive cardiomyopathy V. dissecting aortic aneurysm which is diagnosed by hearing a murmur in the abdominal region of the patient. now the problem here is that the intima and the media layers of the abdominal aorta are separated and the blood flow will have a pattern of turbulence, complicated by an increase in the blood pressure the problem will worsen as more blood hits the abnormally structured blood vessel, and that s why the pressure lowering beta blockers are used. VI. as we ve mentioned before as a conjugated therapy composed of early introduced alpha blockers and later on beta blockers in pre surgical treatment of pheocromcytoma. VII. hyper thyroidism ( mainly as a symptomatic relief medication ). VIII. Migraine prophylaxis (mainly propranolol as it has a BBB penetrating capability because its highly lipid soluble ). IX. Essential tremors as long as its not caused by Parkinson s disease. X. Anxiety XI. Chronic wide angle Glaucoma example is timolol (used topically as drops ) where it acts on decreasing the production of aqueous humor from the cilliary epithelium. In acute narrow angle obstructive glaucoma the drug of choice is pilocarpine with carbacol but for chronic wide angle glaucoma other medications are used such as (alpha adrenergic agonists clonidine, prostaglandin derivatives and carbonic anhydrase inhibitors i.e. duritics These medications however are not substitute for a surgery as the 100% curative measurement is surgery.

15 Table for the aforementioned drugs. General guidelines : **For a patient with hypertension and bradycardia choose the drugs that have an intrinsic sympathomimetic activity (acebutolol,pindolol). **for asthmatic patients use cardio-selective drugs if necessary. **if you want to treat a patient suffering from myocardial infarction make sure that the patient is hemodynamically stable. ** drug shouldn t be withdrawn suddenly instead it must be discontinued gradually over a period of 1-2 weeks because of the up-regulation of the beta receptors in response to the deprivation of the sympathetic flow following the use of beta blockers and thus if the drug is discontinued abruptly rebound hypertension with angina and other complications will develop as some sort of withdrawal syndrome. Side effects : } Cardiac (mechanical; electrical) } Vascular (decreased perfusion)

16 } Pulmonary (bronchocostriction) } Metabolic (fasting hypoglycemia) } Central Nervous System (depression, nightmares, etc.) } Withdrawal Syndrome??

Dr. Vishaal Bhat. anti-adrenergic drugs

Dr. Vishaal Bhat. anti-adrenergic drugs Dr. Vishaal Bhat anti-adrenergic drugs Divisions of human nervous system Human Nervous system Central Nervous System Peripheral Nervous System Autonomic Nervous System Nervous system Includes neurons and

More information

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) Beta-blockers have been widely used in the management of angina, certain tachyarrhythmias and heart failure, as well as in hypertension. Examples

More information

Autonomic Pharmacology

Autonomic Pharmacology Autonomic Pharmacology ADRENERGIC RECEPTOR BLOCKERS Adrenergic-receptor antagonists block the effects of sympathetic stimulation and adrenergic agonists mediated through - and -receptors. Adrenergic receptor

More information

Beta blockers in primary hypertension. Dr. Md. Billal Alam Associate Professor of Medicine DMC

Beta blockers in primary hypertension. Dr. Md. Billal Alam Associate Professor of Medicine DMC Beta blockers in primary hypertension Dr. Md. Billal Alam Associate Professor of Medicine DMC Development of antihypertensive drugs Beta blockers 1958 - The first beta-blocker, dichloroisoproterenol, was

More information

Adrenergic Receptor as part of ANS

Adrenergic Receptor as part of ANS Adrenergic Receptor as part of ANS Actions of Adrenoceptors Beta-1 adrenergic receptor Located on the myocytes of the heart Specific actions of the β1 receptor include: 0 Increase cardiac output, by 0

More information

B-blockers. Effects not related to Beta-Blockade

B-blockers. Effects not related to Beta-Blockade B-blockers Effects not related to Beta-Blockade It has been suggested that some intrinsic sympathomimetic activity is desirable to prevent untoward effects such as asthma or excessive bradycardia. Pindolol

More information

LESSON ASSIGNMENT Given the trade and/or generic name of an adrenergic blocking agent, classify that agent as either an alpha or beta blocker.

LESSON ASSIGNMENT Given the trade and/or generic name of an adrenergic blocking agent, classify that agent as either an alpha or beta blocker. LESSON ASSIGNMENT LESSON 8 Adrenergic Blocking Agents. TEXT ASSIGNMENT Paragraphs 8-1 through 8-5. LESSON OBJECTIVES 8-1. Given a group of statements, select the statement that best describes one of the

More information

Pharmacology of the Sympathetic Nervous System II

Pharmacology of the Sympathetic Nervous System II Pharmacology of the Sympathetic Nervous System II Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828-2127 Department of Pharmacology and Toxicology Medical College of Virginia

More information

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys

More information

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg Lecture 39 Anti-Hypertensives B-Rod BLOOD PRESSURE: Systolic / Diastolic NORMAL: 120/80 Systolic = measure of pressure as heart is beating Diastolic = measure of pressure while heart is at rest between

More information

Adrenergic Receptor Antagonists

Adrenergic Receptor Antagonists Adrenergic Receptor Antagonists α-adrenergic Receptor Antagonists Unlike the β-adrenergic receptor antagonists, which bear clear structural similarities to the adrenergic agonists E, epinephrine, and isoproterenol,

More information

AUTONOMIC DRUGS: ADRENOCEPTOR AGONISTS AND SYMPATHOMIMETICS. Lecture 4

AUTONOMIC DRUGS: ADRENOCEPTOR AGONISTS AND SYMPATHOMIMETICS. Lecture 4 AUTONOMIC DRUGS: ADRENOCEPTOR AGONISTS AND SYMPATHOMIMETICS Lecture 4 Introduction (review) 5 key features of neurotransmitter function, which can be targets for pharmacotherapy Synthesis Storage Release

More information

Dr Laith M Abbas Al-Huseini M.B.Ch.B, M.Sc., M.Res., Ph.D.

Dr Laith M Abbas Al-Huseini M.B.Ch.B, M.Sc., M.Res., Ph.D. Dr Laith M Abbas Al-Huseini M.B.Ch.B, M.Sc., M.Res., Ph.D. Nervous system Includes neurons and ganglia outside of the brain and spinal cord Nervous System *Either fight and flight mode or rest and digest

More information

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias

More information

Beta 1 Beta blockers A - Propranolol,

Beta 1 Beta blockers A - Propranolol, Pharma Lecture 3 Beta blockers that we are most interested in are the ones that target Beta 1 receptors. Beta blockers A - Propranolol, it s a non-selective competitive antagonist of beta 1 and beta 2

More information

(Second) #11. made by laith sorour corrected by. date 27/10

(Second) #11. made by laith sorour corrected by. date 27/10 (Second) #11 made by laith sorour corrected by date 27/10 Pre-lecture ( min 3.0) *last lecture we talked about parasympathetic nervous system about cholinergic drugs(agonists) & anti-cholinergic drugs(antagonists)

More information

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment Approaches to Hypertension Treatment Antihypertensives Inhibit Sympathetic impulses Inhibit contractility Inhibit heart rate Inhibit vasoconstriction Inhibit smooth muscle function Inhibit RAAS Inhibit

More information

β adrenergic blockade, a renal perspective Prof S O McLigeyo

β adrenergic blockade, a renal perspective Prof S O McLigeyo β adrenergic blockade, a renal perspective Prof S O McLigeyo Carvedilol Third generation β blocker (both β 1 and β 2 ) Possesses α 1 adrenergic blocking properties. β: α blocking ratio 7:1 to 3:1 Antioxidant

More information

Systemic Pharmacology Lecture 7: Neuropharmacology

Systemic Pharmacology Lecture 7: Neuropharmacology Systemic Pharmacology Lecture 7: Neuropharmacology Drugs act on Sympathetic NS (adrenergic system) Adrenergic Drugs (Sympathomimetics), adrenergic agonists, or alpha- and beta-adrenergic agonists Antiadrenergic

More information

Adrenoceptor antagonist drugs chapter 10

Adrenoceptor antagonist drugs chapter 10 Adrenoceptor antagonist drugs chapter 10 Overview The adrenergic antagonists (also called blockers or sympatholytic agents) bind to adrenoceptors but do not trigger the usual receptor-mediated intracellular

More information

Alpha Adrenoceptor Antagonists Beta Adrenoceptor Antagonists Ganglion-Blocking Drugs

Alpha Adrenoceptor Antagonists Beta Adrenoceptor Antagonists Ganglion-Blocking Drugs Alpha Adrenoceptor Antagonists Beta Adrenoceptor Antagonists Ganglion-Blocking Drugs 1 Alpha-Receptor Antagonist Drugs Pharmacologic Effects Cardiovascular Effects Decrease peripheral vascular resistance

More information

Adrenergic Antagonists

Adrenergic Antagonists Adrenergic Antagonists 7 I. OVERVIEW The adrenergic antagonists (also called blockers or sympatholytic agents) bind to adrenoceptors but do not trigger the usual receptor-mediated intracellular effects.

More information

sympatholytics sympatholytics sympatholytics

sympatholytics sympatholytics sympatholytics sympatholytics sympatholytics sympatholytics CNS-ACTING SYMPATHOPLEGICS Sympathetic brain signals Doesn t affect baroreceptor reflex (no orthostatic hypotension) Methyldopa α-methylne crosses BBB (+) α-adrenoreceptors

More information

BIMM118. Autonomic Nervous System

BIMM118. Autonomic Nervous System Autonomic Nervous System Autonomic Nervous System Ganglia close to the innervated organs Myelinated axons Ganglia close to the spinal column Preganglionic axons are myelinated; postganglionic axons are

More information

These drugs produce effects similar to the sympathetic nervous system

These drugs produce effects similar to the sympathetic nervous system Terms adrenergic Drugs mydriasis sympathetic nervous system adrenergic drugs adrenergic mechanism of action positive inotropic effect positive chronotropic effect positive dromotropic effect adrenergic

More information

Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2011

Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2011 Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed : October 2009 Most recently updated: September 2011 To identify the patients who should receive a beta blocker

More information

Antihypertensive drugs SUMMARY Made by: Lama Shatat

Antihypertensive drugs SUMMARY Made by: Lama Shatat Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone

More information

Integrated Cardiopulmonary Pharmacology Third Edition

Integrated Cardiopulmonary Pharmacology Third Edition Integrated Cardiopulmonary Pharmacology Third Edition Chapter 3 Pharmacology of the Autonomic Nervous System Multimedia Directory Slide 19 Slide 37 Slide 38 Slide 39 Slide 40 Slide 41 Slide 42 Slide 43

More information

Alpha Receptor Antagonists

Alpha Receptor Antagonists Note: letters between brackets correspond to the drugs names. They help in memorizing, ignore them if u wish xp Alpha Receptor Antagonists 1- Cardiovascular Effects: - Stimulation of alpha receptors has

More information

BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1

BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1 BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1 Terms you should understand: hemorrhage, intrinsic and extrinsic mechanisms, anoxia, myocardial contractility, residual

More information

METOTRUST XL-25/50 Metoprolol Succinate Extended-Release Tablets

METOTRUST XL-25/50 Metoprolol Succinate Extended-Release Tablets METOTRUST XL-25/50 Metoprolol Succinate Extended-Release Tablets COMPOSITION Each film-coated tablet of Metotrust XL-25 contains: Metoprolol Succinate USP 23.75 mg equivalent to Metoprolol Tartrate 25

More information

M2 TEACHING UNDERSTANDING PHARMACOLOGY

M2 TEACHING UNDERSTANDING PHARMACOLOGY M2 TEACHING UNDERSTANDING PHARMACOLOGY USING CVS SYSTEM AS AN EXAMPLE NIGEL FONG 2 JAN 2014 TODAY S OBJECTIVE Pharmacology often seems like an endless list of mechanisms and side effects to memorize. To

More information

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias 1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias Only need to know drugs discussed in class At the end of this section you should

More information

a)-catecholamines // these are compounds which have the catechol nucleus as adrenaline, noradrenaline, isoprenaline, dopamine, dobutamine

a)-catecholamines // these are compounds which have the catechol nucleus as adrenaline, noradrenaline, isoprenaline, dopamine, dobutamine 1 Adrenergic or sympathetic agonist: Are classified according to: I)- according to the chemical structure a)-catecholamines // these are compounds which have the catechol nucleus as adrenaline, noradrenaline,

More information

Alpha adrenergic blockers

Alpha adrenergic blockers Alpha adrenergic blockers Introduction Drugs which antagonize the receptor action of Adrenaline and other related drugs at the receptor level They occupy adrenergic receptors (α and β ) but do not produce

More information

I. BASIC PHARMACOLOGY OF THE ALPHA-RECEPTOR ANTAGONIST DRUGS

I. BASIC PHARMACOLOGY OF THE ALPHA-RECEPTOR ANTAGONIST DRUGS Adrenoceptor Antagonist Drugs INTRODUCTION Since catecholamines play a role in a variety of physiologic and pathophysiologic responses, drugs that block adrenoceptors have important effects, some of which

More information

Autonomic Nervous System

Autonomic Nervous System Autonomic Nervous System Keri Muma Bio 6 Organization of the Nervous System Efferent Division Somatic Nervous System Voluntary control Effector = skeletal muscles Muscles must be excited by a motor neuron

More information

Pharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs)

Pharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs) Lecture 7 (year3) Dr Noor Al-Hasani Pharmacology University of Baghdad College of dentistry Drugs affecting the Cardiovascular system (Antianginal Drugs) Atherosclerotic disease of the coronary arteries,

More information

LESSON ASSIGNMENT. After completing this lesson you will be able to:

LESSON ASSIGNMENT. After completing this lesson you will be able to: LESSON ASSIGNMENT SUBCOURSE MD0806 LESSON 7 Therapeutics III. Antihypertensive Agents. LESSON ASSIGNMENT Paragraphs 7-1--7-12. LESSON OBJECTIVES After completing this lesson you will be able to: 7-1. From

More information

Arrhythmias. 1. beat too slowly (sinus bradycardia). Like in heart block

Arrhythmias. 1. beat too slowly (sinus bradycardia). Like in heart block Arrhythmias It is a simple-dysfunction caused by abnormalities in impulse formation and conduction in the myocardium. The heart is designed in such a way that allows it to generate from the SA node electrical

More information

Hypertensives Emergency and Urgency

Hypertensives Emergency and Urgency Hypertensives Emergency and Urgency Budi Yuli Setianto Cardiology Divisision Department of Internal Medicine Faculty of Medicine UGM Sardjito Hospital Yogyakarta Background USA: Hypertension is 30% of

More information

Allergy Testing Information

Allergy Testing Information Allergy Testing Information Allergy skin testing takes approximately 1 to 1 ½ hours. Please eat a light breakfast if you are scheduled for a morning appointment. DO NOT SKIP BREAKFAST. If you are scheduled

More information

Core Safety Profile. Pharmaceutical form(s)/strength: Film-coated tablets 1.25 mg, 2.5 mg, 3.75 mg, 5 mg, 7.5 mg and 10 mg. Date of FAR:

Core Safety Profile. Pharmaceutical form(s)/strength: Film-coated tablets 1.25 mg, 2.5 mg, 3.75 mg, 5 mg, 7.5 mg and 10 mg. Date of FAR: Core Safety Profile Active substance: Bisoprolol Pharmaceutical form(s)/strength: Film-coated tablets 1.25 mg, 2.5 mg, 3.75 mg, 5 mg, 7.5 mg and 10 mg P - RMS: FI/H/PSUR/0002/002 Date of FAR: 13.12.2011

More information

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris. Lonet Tablet Description Lonet contains Atenolol, a synthetic β1 selective (cardioselective) adrenoreceptor blocking agent without membrane stabilising or intrinsic sympathomimetic (partial agonist) activity.

More information

IMPORTANT INFORMATION REGARDING YOUR NUCLEAR STRESS TEST

IMPORTANT INFORMATION REGARDING YOUR NUCLEAR STRESS TEST Name: Day One Appointment Day Two Appointment Test Results Appointment Time: Time: Time: IMPORTANT INFORMATION REGARDING YOUR NUCLEAR STRESS TEST A Stress test sometimes also called a treadmill test, helps

More information

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology Cardiovascular Disorders Bio 375 Pathophysiology Heart Disorders Heart disease is ranked as a major cause of death in the U.S. Common heart diseases include: Congenital heart defects Hypertensive heart

More information

Angina Pectoris Dr. Shariq Syed

Angina Pectoris Dr. Shariq Syed Angina Pectoris Dr. Syed 1 What is Angina Pectoris (AP)? Commonly known as angina is chest pain often due to ischemia of the heart muscle, Because of obstruction or spasm of the coronary arteries 2 What

More information

Prof dr Aleksandar Raskovic DIRECT VASODILATORS

Prof dr Aleksandar Raskovic DIRECT VASODILATORS Prof dr Aleksandar Raskovic DIRECT VASODILATORS Direct vasodilators Minoxidil (one of the most powerful peripheral arterial dilators) Opening of KATP channels, efflux of K, lose of Ca and smooth muscle

More information

Pharmacology - Problem Drill 11: Vasoactive Agents

Pharmacology - Problem Drill 11: Vasoactive Agents Pharmacology - Problem Drill 11: Vasoactive Agents Question No. 1 of 10 1. Vascular smooth muscle contraction is triggered by a rise in. Question #01 (A) Luminal calcium (B) Extracellular calcium (C) Intracellular

More information

Chapter 26. Media Directory. Dysrhythmias. Diagnosis/Treatment of Dysrhythmias. Frequency in Population Difficult to Predict

Chapter 26. Media Directory. Dysrhythmias. Diagnosis/Treatment of Dysrhythmias. Frequency in Population Difficult to Predict Chapter 26 Drugs for Dysrythmias Slide 33 Slide 35 Media Directory Propranolol Animation Amiodarone Animation Upper Saddle River, New Jersey 07458 All rights reserved. Dysrhythmias Abnormalities of electrical

More information

10/26/2015 HIGH DOSE INSULIN IN BETA BLOCKER AND CALCIUM CHANNEL BLOCKER OVERDOSE. Session # 5 C

10/26/2015 HIGH DOSE INSULIN IN BETA BLOCKER AND CALCIUM CHANNEL BLOCKER OVERDOSE. Session # 5 C HIGH DOSE INSULIN IN BETA BLOCKER AND CALCIUM CHANNEL BLOCKER OVERDOSE Session # 5 C 1 TOM SCULLARD RN MSN CCRN CLINICAL CARE SUPERVISOR MEDICAL INTENSIVE CARE UNIT HENNEPIN COUNTY MEDICAL CENTER MINNEAPOLIS

More information

Pharmacology Second. - Contraction of detrusor muscle in the bladder.

Pharmacology Second. - Contraction of detrusor muscle in the bladder. Pharmacology Second 1) Which of the following is correct regarding the autonomic nervous system (ANS)? - Afferent neurons carry signals from the CNS to the effector organs. - The neurotransmitter at the

More information

Cardiovascular Pharmacotherapy

Cardiovascular Pharmacotherapy Cardiovascular Pharmacotherapy Overview Mechanism of cardiovascular drugs Indications and clinical use in cardiology Renin-Angiotensin Inhibitors: Angiotensin-Converting Enzyme Inhibitors, Angiotensin

More information

A. Incorrect! Acetazolamide is a carbonic anhydrase inhibitor given orally or by intravenous injection.

A. Incorrect! Acetazolamide is a carbonic anhydrase inhibitor given orally or by intravenous injection. Pharmacology - Problem Drill 20: Drugs that Treat Glaucoma Question No. 1 of 10 1. is a topical carbonic anhydrase inhibitor. Question #01 (A) Acetazolamide (B) Clonidine (C) Dorzolamide (D) Apraclonidine

More information

Comparison of Oral Beta-Blockers

Comparison of Oral Beta-Blockers This Clinical Resource gives subscribers additional insight related to the Recommendations published in March 2017 ~ Resource #330356 Comparison of Oral Beta-Blockers Noncardioselective s (beta-1 and beta-2

More information

Properties of Pressure

Properties of Pressure OBJECTIVES Overview Relationship between pressure and flow Understand the differences between series and parallel circuits Cardiac output and its distribution Cardiac function Control of blood pressure

More information

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output. Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries

More information

Definition of Congestive Heart Failure

Definition of Congestive Heart Failure Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million

More information

Lujain Hamdan. Ayman Musleh & Yahya Salem. Mohammed khatatbeh

Lujain Hamdan. Ayman Musleh & Yahya Salem. Mohammed khatatbeh 12 Lujain Hamdan Ayman Musleh & Yahya Salem Mohammed khatatbeh the last lecture, we have studied the differences between the two divisions of the ANS: sympathetic and parasympathetic pathways which work

More information

Heart Failure (HF) Treatment

Heart Failure (HF) Treatment Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and

More information

Pharmacotherapy of Angina Pectoris

Pharmacotherapy of Angina Pectoris Pharmacotherapy of Angina Pectoris Edward JN Ishac, Ph.D. Smith Building, Room 742 eishac@vcu.edu 828-2127 Department of Pharmacology and Toxicology Medical College of Virginia Campus of Virginia Commonwealth

More information

IV. DIRECT-ACTING ADRENERGIC AGONISTS

IV. DIRECT-ACTING ADRENERGIC AGONISTS IV. Direct-Acting Adrenergic Agonists 1 IV. DIRECT-ACTING ADRENERGIC AGONISTS A. Epinephrine B. Norepinephrine Because norepinephrine [nor-ep-ih-nef-rin] is the neurotransmitter of adrenergic nerves, it

More information

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine

More information

Pharmacotherapy of Angina Pectoris

Pharmacotherapy of Angina Pectoris Pharmacotherapy of Angina Pectoris Edward JN Ishac, Ph.D. Smith Building, Room 742 eishac@vcu.edu 828-2127 Department of Pharmacology and Toxicology Medical College of Virginia Campus of Virginia Commonwealth

More information

Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide

Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide Main Idea: The function of the circulatory system is to maintain adequate blood flow to all tissues. Clinical

More information

Byvalson. (nebivolol, valsartan) New Product Slideshow

Byvalson. (nebivolol, valsartan) New Product Slideshow Byvalson (nebivolol, valsartan) New Product Slideshow Introduction Brand name: Byvalson Generic name: Nebivolol, valsartan Pharmacological class: Beta-blocker + angiotensin II receptor blocker (ARB) Strength

More information

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Antihypertensive Agents Part-2 Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Agents that block production or action of angiotensin Angiotensin-converting

More information

Structure and organization of blood vessels

Structure and organization of blood vessels The cardiovascular system Structure of the heart The cardiac cycle Structure and organization of blood vessels What is the cardiovascular system? The heart is a double pump heart arteries arterioles veins

More information

Autonomic Nervous System (ANS) وحدة اليوزبكي Department of Pharmacology- College of Medicine- University of Mosul

Autonomic Nervous System (ANS) وحدة اليوزبكي Department of Pharmacology- College of Medicine- University of Mosul Autonomic Nervous System (ANS) د. م. أ. وحدة اليوزبكي Department of Pharmacology- College of Medicine- University of Mosul Sympathetic (Adrenergic) nervous system 3 Objectives At end of this lecture, the

More information

Constriction and dilatation of blood vessels. Contraction and relaxation of smooth muscle in various organs. Visual accommodation, pupillary size.

Constriction and dilatation of blood vessels. Contraction and relaxation of smooth muscle in various organs. Visual accommodation, pupillary size. The Autonomic Nervous System (ANS) Dr. L. Al tmimi Academic year 2011-2012 This text is focused mostly on the anatomy and physiology of the Autonomic Nervous System (ANS), more specifically, about the

More information

REGULATION OF CARDIOVASCULAR SYSTEM

REGULATION OF CARDIOVASCULAR SYSTEM REGULATION OF CARDIOVASCULAR SYSTEM Jonas Addae Medical Sciences, UWI REGULATION OF CARDIOVASCULAR SYSTEM Intrinsic Coupling of cardiac and vascular functions - Autoregulation of vessel diameter Extrinsic

More information

Titrating Critical Care Medications

Titrating Critical Care Medications Titrating Critical Care Medications Chad Johnson, MSN (NED), RN, CNCC(C), CNS-cc Clinical Nurse Specialist: Critical Care and Neurosurgical Services E-mail: johnsoc@tbh.net Copyright 2017 1 Learning Objectives

More information

Treatment of T Angina reatment of By Ali Alalawi

Treatment of T Angina reatment of By Ali Alalawi Treatment of Angina By Ali Alalawi Determinants of Oxygen Demand Need to improve ratio of: Coronary blood flow / cardiac work Or Cardiac O2 Supply / Cardiac Requirement Coronary Circulation vs Other Circulation

More information

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.

More information

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid Failure? blood supply insufficient for body needs CHF = congestive heart failure increased blood volume, interstitial fluid Underlying causes/risk factors Ischemic heart disease (CAD) 70% hypertension

More information

Antihypertensives. Diagnostic category

Antihypertensives. Diagnostic category Measurement of blood pressure At first assessment, take both arms then choose the one with the higher reading. Beware of orthostatic hypotension. Measure BP in sitting position, and repeat after patient

More information

Role of Sympathetic Nervous System in Hypertension

Role of Sympathetic Nervous System in Hypertension Role of Sympathetic Nervous System in Hypertension BP = CO x PVR SV HR DEFENSE REACTION Suppressed vagal activity Increased sympathetic activity to heart, veins, kidneys, splachnic region, skin Skeletal

More information

Should beta blockers remain first-line drugs for hypertension?

Should beta blockers remain first-line drugs for hypertension? 1 de 6 03/11/2008 13:23 Should beta blockers remain first-line drugs for hypertension? Maros Elsik, Cardiologist, Department of Epidemiology and Preventive Medicine, Monash University and The Alfred Hospital,

More information

Antihypertensive Agents

Antihypertensive Agents Antihypertensive Agents Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 7, 08, presented by Ezra Levy, Pharm.D! Usual Dose,

More information

Cardiovascular Drugs and Therapies BETA-ADRENERGIC RECEPTOR BLOCKING AGENTS

Cardiovascular Drugs and Therapies BETA-ADRENERGIC RECEPTOR BLOCKING AGENTS Generic Name Acebutolol Atenolol Bisoprolol Carvedilol Esmolol IV Trade Name Dosage Forms SECTRAL, 100 mg, 200 mg, 400 mg tablet TENORMIN, 25 mg, 50 mg, 100 mg tablet MONOCOR, 5 mg, 10 mg tablet 3.125

More information

PHARMACOLOGICAL PROBLEMS

PHARMACOLOGICAL PROBLEMS PHARMACOLOGICAL PROBLEMS 1. A 69 year old woman suffering from CHF has been treated with.25 mg Digoxin tablet daily for last 3 months. But the heart failure is not controlled adequately. What will be the

More information

BETAGAN Allergan Levobunolol HCl Glaucoma Therapy

BETAGAN Allergan Levobunolol HCl Glaucoma Therapy BETAGAN Allergan Levobunolol HCl Glaucoma Therapy Action And Clinical Pharmacology: Levobunolol is a noncardioselective beta- adrenoceptor antagonist, equipotent at both beta1 and beta2 receptors. Levobunolol

More information

Cardiovascular System B L O O D V E S S E L S 2

Cardiovascular System B L O O D V E S S E L S 2 Cardiovascular System B L O O D V E S S E L S 2 Blood Pressure Main factors influencing blood pressure: Cardiac output (CO) Peripheral resistance (PR) Blood volume Peripheral resistance is a major factor

More information

Cardiac Pathophysiology

Cardiac Pathophysiology Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of

More information

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for

More information

Antianginal Drugs 18 I. OVERVIEW II. TYPES OF ANGINA

Antianginal Drugs 18 I. OVERVIEW II. TYPES OF ANGINA Antianginal Drugs 18 I. OVERVIEW Atherosclerotic disease of the coronary arteries, also known as coronary artery disease or ischemic heart disease, is the most common cause of mortality around the world.

More information

Adrenergic agonists Sympathomimetic drugs. ANS Pharmacology Lecture 4 Dr. Hiwa K. Saaed College of Pharmacy/University of Sulaimani

Adrenergic agonists Sympathomimetic drugs. ANS Pharmacology Lecture 4 Dr. Hiwa K. Saaed College of Pharmacy/University of Sulaimani Adrenergic agonists Sympathomimetic drugs ANS Pharmacology Lecture 4 Dr. Hiwa K. Saaed College of Pharmacy/University of Sulaimani 2017-2018 Adrenergic agonists The adrenergic drugs affect receptors that

More information

Homeostasis. Achievement Criteria. Excellence Criteria. Demonstrate understanding of how an animal maintains a stable internal environment 10/02/2016

Homeostasis. Achievement Criteria. Excellence Criteria. Demonstrate understanding of how an animal maintains a stable internal environment 10/02/2016 Homeostasis Demonstrate understanding of how an animal maintains a stable internal environment Biology 3.4 AS91604 Achievement Criteria Explain the purpose of the homeostatic mechanism Be able to explain

More information

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP What is normal blood pressure? Prehypertension 130-139/80-90 Compared with normal BP Double the risk for developing hypertension. Lifestyle

More information

10. Thick deposits of lipids on the walls of blood vessels, called, can lead to serious circulatory issues. A. aneurysm B. atherosclerosis C.

10. Thick deposits of lipids on the walls of blood vessels, called, can lead to serious circulatory issues. A. aneurysm B. atherosclerosis C. Heart Student: 1. carry blood away from the heart. A. Arteries B. Veins C. Capillaries 2. What is the leading cause of heart attack and stroke in North America? A. alcohol B. smoking C. arteriosclerosis

More information

REGULATION OF BLOOD PRESSURE

REGULATION OF BLOOD PRESSURE Minute-to-minute control of arterial blood pressure is achieved when small pressure changes are linked to reflex alterations in autonomic nerve activity. Sensory nerve endings embedded in the wall of the

More information

The adrenergic drugs affect receptors that are stimulated by norepinephrine or epinephrine. Some adrenergic drugs act directly on the adrenergic

The adrenergic drugs affect receptors that are stimulated by norepinephrine or epinephrine. Some adrenergic drugs act directly on the adrenergic Adrenergic drugs The adrenergic drugs affect receptors that are stimulated by norepinephrine or epinephrine. Some adrenergic drugs act directly on the adrenergic receptor (adrenoceptor) by activating it

More information

ANTI - ARRHYTHMIC DRUGS

ANTI - ARRHYTHMIC DRUGS ANTI - ARRHYTHMIC DRUGS CARDIAC ACTION POTENTIAL K Out Balance Ca in/k out Na in K Out GENERATION OF ARRHYTHMIAS Four mechanisms of arrhythmia generation; Increased normal automaticity Abnormal automaticity

More information

Categories of HTN. Overview of Hypertension. Types of Hypertension

Categories of HTN. Overview of Hypertension. Types of Hypertension Categories of HTN Overview of Hypertension Normal SBP 100 Quick review of the Basics: What is

More information

The Cardiovascular System

The Cardiovascular System The Cardiovascular System The Cardiovascular System A closed system of the heart and blood vessels The heart pumps blood Blood vessels allow blood to circulate to all parts of the body The function of

More information

ANGINA PECTORIS. angina pectoris is a symptom of myocardial ischemia in the absence of infarction

ANGINA PECTORIS. angina pectoris is a symptom of myocardial ischemia in the absence of infarction Pharmacology Ezra Levy, Pharm.D. ANGINA PECTORIS A. Definition angina pectoris is a symptom of myocardial ischemia in the absence of infarction angina usually implies severe chest pain or discomfort during

More information

Management of Hypertension

Management of Hypertension Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal

More information

The Autonomic Nervous System

The Autonomic Nervous System The Autonomic Nervous System Responsible for control of visceral effectors and visceral reflexes: smooth muscle, glands, the heart. e.g. blood pressure, cardiac output, plasma glucose The autonomic system

More information

Beta Adrenergic Blockers

Beta Adrenergic Blockers Oregon Health Resources Commission Beta Adrenergic Blockers Subcommittee Report March 2004 Produced by: Health Resources Commission Kathleen Weaver, MD, Director Office for Health Policy & Research 255

More information

Ganglionic Blockers. Ganglion- blocking agents competitively block the action of

Ganglionic Blockers. Ganglion- blocking agents competitively block the action of Ganglionic Blockers Ganglion- blocking agents competitively block the action of acetylcholine and similar agonists at nicotinic (Nn) receptors of both parasympathetic and sympathetic autonomic ganglia.

More information